Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZLI for Early BOS After Lung Transplant
NCT01469364Phase 4Completed
- Sponsor
- Duke University
- Start
- Mar 2013
- Primary completion
- Mar 2015
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aztreonam in Bronchiolitis Obliterans Syndrome (BOS), sponsored by Duke University. Started Mar 2013; status: completed.
02
Drugs
aztreonam
03
Conditions
Bronchiolitis Obliterans Syndrome (BOS)
Beyond the preview
Go deeper on NCT01469364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01469364.